HSCI 705 Philosophy of Ethics in Research Paper: Mission Statement, Ethical Philosophy and Research Dilemmas

HSCI 705 Philosophy of Ethics in Research Paper: Mission Statement, Ethical Philosophy and Research Dilemmas

Write a 12–15 page paper (body only; double-spaced APA with at least 5 biblical verses and 10 sources from peer-reviewed research and textbooks) expressing your identity and values about ethics in research, thoughtfully expressed and defended, as a foundation for future actions that are honest, courageous and consistent with your beliefs.

• Introduction: a brief summary of ethics in human subjects research.
• Body: your mission statement and ethical philosophy, and how they guide you through ethical dilemmas from the course readings and discussions in publication, data management, protection of human subjects, protection of animal subjects, the role of the IRB and informed consent and mentorship.
• Conclusion: a brief summary and ideas for future evaluation of your ethical philosophy.

Original example for study purposes (about 3,380 words). About 12 double-spaced pages of body text in the Word version. Your mission statement and examples must reflect your own beliefs and the specific dilemmas from your course.

Introduction

Research involving human beings has produced some of medicine’s greatest advances and some of its most shameful failures. The modern system of research ethics grew out of those failures. After World War II, the Nuremberg Code established that voluntary consent of the human subject is absolutely essential. In the United States, Beecher (1966) documented 22 published studies in which patients were exposed to serious risks without their knowledge or consent, demonstrating that unethical research was not limited to wartime atrocities. The U.S. Public Health Service syphilis study at Tuskegee, in which Black men were observed for 40 years and denied effective treatment after penicillin became available, revealed how racism and the pursuit of data could override researchers’ duty to their participants (Brandt, 1978). Public outrage over Tuskegee led Congress to create the National Commission for the Protection of Human Subjects, whose Belmont Report identified three principles that still anchor research ethics: respect for persons, beneficence and justice (National Commission, 1979). These principles were translated into federal regulations, now known as the Common Rule, which require institutional review board (IRB) oversight and informed consent for most federally funded research (Protection of Human Subjects, 2018). Internationally, the World Medical Association’s Declaration of Helsinki, most recently revised in October 2024, sets ethical standards for medical research involving human participants (World Medical Association [WMA], 2024).

Rules and regulations, however, cannot anticipate every situation a researcher will face. Emanuel et al. (2000) argued that ethical research requires more than consent forms: it must have social value, scientific validity, fair subject selection, a favorable risk-benefit ratio, independent review, informed consent and respect for enrolled participants. Meeting these requirements in real situations depends on the character and convictions of the researcher. This paper presents my personal mission statement and ethical philosophy as a health sciences researcher and explains how they will guide my decisions about publication, data management, the protection of human and animal subjects, the role of the IRB and informed consent and mentorship. It concludes with a plan for continuing to evaluate my philosophy throughout my career.

Mission Statement

As a Christian health sciences researcher, my mission is to pursue knowledge that improves human health with integrity, humility and compassion; to honor the dignity of every research participant as a person created in the image of God; to report my work honestly and completely; to care responsibly for the animals and resources entrusted to me; and to train others to conduct research with the same commitments.

This statement reflects three convictions. First, research is a form of service rather than a path to personal recognition: “Whatever you do, work heartily, as for the Lord and not for men” (Colossians 3:23, English Standard Version). Second, every person has inherent worth that does not depend on their usefulness to a study, because “God created man in his own image” (Genesis 1:27). Third, integrity is not occasional but constant; “the integrity of the upright guides them, but the crookedness of the treacherous destroys them” (Proverbs 11:3).

Ethical Philosophy

My ethical philosophy combines principle-based ethics with virtue ethics, grounded in a Christian worldview. The Belmont principles provide a shared language that I can use with colleagues of any background. Respect for persons requires treating individuals as autonomous agents and protecting those with diminished autonomy; beneficence requires maximizing possible benefits and minimizing possible harms; and justice requires a fair distribution of the burdens and benefits of research (National Commission, 1979). These principles can conflict, as when the benefits of a study for future patients must be weighed against risks to current participants, and they do not resolve every dilemma on their own.

Virtue ethics fills this gap by asking not only “What rule applies?” but “What would a person of integrity do?” Shamoo and Resnik (2022) emphasize that responsible conduct of research depends on researchers who value honesty, openness, carefulness, fairness and social responsibility. My faith shapes these virtues. The prophet Micah summarized what God requires: “to do justice, and to love kindness, and to walk humbly with your God” (Micah 6:8). Justice calls me to protect vulnerable participants and to share credit fairly; kindness calls me to treat participants and trainees with compassion; and humility calls me to acknowledge the limits of my findings and to welcome correction. The Golden Rule provides a practical test for many decisions: “So whatever you wish that others would do to you, do also to them” (Matthew 7:12). Before asking participants to accept a risk, I ask whether I would be willing to accept it for myself or someone I love under the same conditions.

In practice, my decision-making process follows four steps: (1) identify the people affected and the relevant facts; (2) identify the applicable regulations, policies and professional standards; (3) weigh the Belmont principles and the virtues of honesty, fairness and compassion; and (4) choose the option I could openly explain to participants, colleagues, the public and God. When I am uncertain, I seek counsel from mentors, the IRB or research integrity officers rather than deciding alone.

Sources of My Ethical Commitments

My ethical philosophy did not begin in this course. It was shaped by family members who modeled honesty in small matters, by clinical and professional experiences in which I saw how much patients depend on the trustworthiness of those who care for them and by Scripture’s repeated call to protect the vulnerable. Studying the history of research ethics has sharpened these commitments. Reading the accounts Beecher (1966) compiled, I was struck that most of the researchers involved were not villains but respected professionals who had persuaded themselves that the importance of their questions justified the risks they imposed on others. That realization makes me humble about my own capacity for self-deception. Good intentions are not enough; I need explicit commitments, external review and honest friends who will challenge me.

My philosophy also recognizes that ethical obligations extend beyond individual participants to the public that funds and relies on research. Taxpayers, patients and clinicians trust that published findings are accurate and that research dollars are used responsibly. Every shortcut I take, whether a careless analysis or an exaggerated abstract, erodes that trust. For this reason, I treat carefulness as a moral virtue, not merely a technical skill.

Applying My Philosophy to Ethical Dilemmas

Publication

Publication ethics involves honesty in reporting results, fairness in authorship and transparency about conflicts of interest. The most serious violations are fabrication, falsification and plagiarism. A meta-analysis of surveys found that about 2% of scientists admitted to fabricating or falsifying data at least once, and about 34% admitted to other questionable research practices (Fanelli, 2009). The case of Andrew Wakefield, whose 1998 paper linking the MMR vaccine to autism was retracted after investigations found that data had been misrepresented, shows how one fraudulent publication can harm public health for decades (Godlee et al., 2011).

My mission statement commits me to report work “honestly and completely.” Faced with pressure to publish only positive results or to drop inconvenient outliers, I will report all prespecified outcomes, including null findings, and document any changes to the analysis plan. “Lying lips are an abomination to the LORD, but those who act faithfully are his delight” (Proverbs 12:22). For authorship, I will follow the International Committee of Medical Journal Editors (ICMJE, n.d.) criteria: substantial contributions to the work, drafting or critical revision, final approval and accountability. I will discuss authorship order at the start of each project and revisit it as roles change, rather than rewarding seniority or excluding junior contributors. I will disclose all financial and nonfinancial conflicts of interest.

Applying the philosophy to a publication dilemma. Consider a scenario common in course discussions: a principal investigator asks a junior researcher to add a department chair as an author because the chair “supports the lab,” even though the chair did not contribute to the work, and to omit a graduate student who collected and cleaned most of the data. Gift authorship and ghost authorship both misrepresent who is responsible for the work. Using my decision process, I would first clarify each person’s actual contributions, then apply the ICMJE criteria, then weigh fairness and honesty. I would respectfully explain to the investigator that the chair could be acknowledged rather than listed as an author and that the graduate student meets the criteria for authorship. If the disagreement could not be resolved, I would seek guidance from the institution’s research integrity office. This approach protects the integrity of the record and the student’s career while showing respect to everyone involved.

Conflicts of interest. Financial ties to industry, such as consulting fees or equity, can subtly shape study design, interpretation and publication decisions even when researchers believe they are objective. My philosophy requires me to disclose such interests fully, to accept management plans such as independent data monitoring and to decline relationships that would compromise my independence. Humility reminds me that I am not immune to bias simply because I intend to be fair.

Data Management

Good data management protects both scientific integrity and participants’ privacy. The National Institutes of Health now requires researchers to submit a data management and sharing plan and to share scientific data when appropriate, a policy that took effect in January 2023 (National Institutes of Health [NIH], 2020). My philosophy guides data management in three ways. First, carefulness: I will use written protocols, version control and audit trails so that analyses can be reproduced. Second, honesty: I will retain raw data and never alter data to fit expectations. Third, respect for persons: I will protect confidentiality through de-identification, secure storage and access limits, and I will share data only in ways consistent with participants’ consent.

The Havasupai case illustrates why. Blood samples collected from members of the Havasupai Tribe for diabetes research were later used for studies of schizophrenia, inbreeding and population migration that the tribe considered offensive and had not agreed to, leading to a lawsuit and the return of samples (Mello & Wolf, 2010). If I hold data or biospecimens, I will use them only within the scope of consent, consult communities about secondary uses and treat participants’ data as a trust rather than a resource I own.

Applying the philosophy to a data dilemma. Suppose that, near a grant deadline, I discover that several survey responses were entered twice and that removing them weakens a statistically significant result. My commitment to honesty requires me to correct the data set, rerun the analysis and report the corrected result, even if it delays the grant or weakens the findings. I would also document the error and the correction in the study records. If the error had already appeared in a publication, I would contact the journal to issue a correction. Trust in science depends on researchers who correct their own mistakes rather than waiting for others to discover them.

Emerging data challenges. Large electronic health record data sets, genomic data and artificial intelligence tools create new ethical questions. De-identified data can sometimes be re-identified when combined with other sources, and algorithms trained on biased data can reproduce health disparities. My philosophy calls me to apply the principle of justice to these tools: to evaluate whether data sets represent the populations they will affect, to test models for biased performance and to be transparent about limitations. I also need to consider whether broad consent for future research truly respects participants when the future uses are difficult to predict.

Protection of Human Subjects

Protecting human subjects is the heart of my mission to “honor the dignity of every research participant.” The story of Henrietta Lacks, whose cancer cells were taken in 1951 without her knowledge and became the widely used HeLa cell line, raises enduring questions about consent, privacy and benefit sharing for families and communities. The death of Jesse Gelsinger in a 1999 gene therapy trial, in which reviews later identified problems with adverse event reporting and conflicts of interest, shows that even well-intentioned researchers can endanger participants when enthusiasm outweighs caution.

My philosophy leads me to several commitments. I will design studies so that risks are minimized and reasonable in relation to anticipated benefits; I will apply additional protections for vulnerable groups such as children, prisoners, pregnant people and people with impaired decision-making capacity; and I will stop or modify a study when new information shows unacceptable risk. Justice requires that I not recruit participants simply because they are convenient or easily persuaded, as happened at Tuskegee, and that communities bearing research burdens have access to its benefits. Philippians 2:3–4 reminds me to “count others more significant than yourselves” and to look “to the interests of others”; in research, this means participants’ welfare takes priority over my career goals.

Applying the philosophy to a recruitment dilemma. Imagine a study that offers substantial payments to participants for a procedure with moderate risk, and recruitment is planned at a homeless shelter because enrollment there is fast. Payment is not wrong in itself, but large incentives offered to people in financial distress can undermine voluntary choice, and concentrating risk among the poor raises concerns about justice. Following my philosophy, I would work with the IRB to set payment at a level that compensates time and inconvenience without becoming coercive, broaden recruitment so that the burdens are shared more fairly and ensure that participants can withdraw at any time without losing the compensation they have earned. Asking whether I would want my own family member recruited this way provides a final check.

Protection of Animal Subjects

Although my primary work involves human participants, health sciences research often depends on animal studies. Scripture teaches that “whoever is righteous has regard for the life of his beast” (Proverbs 12:10), which I understand as a call to stewardship rather than indifference. The principles of replacement, reduction and refinement, known as the 3Rs, provide a practical framework: replace animals with alternatives such as cell cultures or computer models when possible, reduce the number of animals to the minimum needed for valid results and refine procedures to minimize pain and distress (Russell & Burch, 1959). In the United States, institutions receiving Public Health Service funding must follow the PHS Policy on Humane Care and Use of Laboratory Animals and have an Institutional Animal Care and Use Committee review protocols (Office of Laboratory Animal Welfare [OLAW], 2015). If I participate in animal research, I will justify the use of animals scientifically, ensure that all personnel are trained, report concerns about animal welfare and support transparent reporting of methods so that experiments are not unnecessarily repeated.

The Role of the IRB and Informed Consent

The IRB provides independent review to ensure that risks are minimized, selection is equitable, consent is properly obtained and privacy is protected (Protection of Human Subjects, 2018). Some researchers view the IRB as a bureaucratic obstacle. My philosophy views it as an expression of humility: I may be too invested in my own study to see its risks clearly, and independent reviewers help protect participants and me from my blind spots. I will submit complete, honest protocols, respond to IRB concerns in good faith and report adverse events and protocol deviations promptly.

Informed consent is a process, not a signature. The revised Common Rule requires that consent forms begin with a concise presentation of key information that helps a person understand why they might or might not want to participate (Protection of Human Subjects, 2018). I will use plain language, check understanding through teach-back, allow time for questions and family discussion, provide consent in participants’ preferred languages and make clear that participation is voluntary and can be withdrawn without penalty. When working with people who have limited decision-making capacity, I will seek legally authorized representatives and respect participants’ assent or dissent. These practices reflect respect for persons and the Golden Rule: I want to be fully informed before accepting risks, and so do my participants.

Mentorship

Mentorship shapes the ethical culture of science, because trainees learn as much from what mentors do as from what they say. The National Academies of Sciences, Engineering, and Medicine (NASEM, 2019) describe effective mentorship as a professional, working alliance that supports both career development and psychosocial growth, and they highlight the importance of mentors’ attention to equity and inclusion. Ethical dilemmas in mentorship include exploiting trainees’ labor, taking credit for their ideas, pressuring them to produce particular results and failing to address harassment or bias.

Paul instructed Timothy to entrust what he had learned “to faithful men, who will be able to teach others also” (2 Timothy 2:2). As a mentor, I will model honesty by discussing my own mistakes, teach responsible conduct of research explicitly, set clear expectations about authorship and data ownership and create an environment in which trainees can raise concerns without fear of retaliation. I will advocate for trainees’ career goals even when those goals take them away from my lab. As a mentee, I will seek mentors whose integrity I admire and ask for guidance when I face difficult decisions.

Applying the philosophy to a mentorship dilemma. Suppose a doctoral student in my lab confides that a postdoctoral colleague has been quietly excluding outliers to make results look cleaner, and the student fears retaliation for speaking up. My commitments to honesty and to protecting those with less power point in the same direction. I would thank the student, document what was shared, review the data myself and, if the concern were substantiated, follow the institution’s research misconduct procedures, while protecting the student from retaliation. I would also examine whether my own lab culture, such as pressure for clean results before conference deadlines, contributed to the problem, and change it.

Integrating Faith and Professional Ethics in a Pluralistic Setting

Most of my colleagues and participants will not share my faith, and research ethics must be practiced in a pluralistic environment. I do not see this as a conflict. The Belmont principles and the commitments in the Declaration of Helsinki overlap substantially with biblical teaching about the dignity of persons, honesty and justice, so I can work alongside colleagues of different beliefs on shared ground. My faith functions less as a separate rulebook and more as the motivation and accountability behind my professional commitments. It also reminds me that participants are never merely data points; each person who enrolls in a study has a story, a family and inherent worth.

At the same time, I must not impose my beliefs on participants or trainees. Respect for persons includes respecting their values, cultures and religious or nonreligious convictions, especially when they differ from mine. In community-based research, for example, I will seek community partners’ input on research questions, consent processes and the dissemination of results, recognizing that communities have their own knowledge and priorities. Where my convictions would prevent me from participating in a particular study, I will disclose that honestly and step aside rather than undermine the work of others.

Summary and Future Reflection

Research ethics has developed in response to harms such as the abuses Beecher exposed, the Tuskegee study and controversies involving Henrietta Lacks and the Havasupai. Regulations, IRBs and principles such as those in the Belmont Report and the Declaration of Helsinki provide essential protections, but they depend on researchers who are committed to doing right when no rule is clear. My mission statement commits me to integrity, humility and compassion; to honoring the dignity of every participant; to honest reporting; to responsible stewardship of animals and data; and to training others. My ethical philosophy combines the Belmont principles with Christian virtues, and it guides concrete practices in publication, data management, human and animal protections, IRB review and informed consent and mentorship.

An ethical philosophy is not finished when it is written. I plan to revisit this statement at key points: before each new study, when I review protocols as a member of an IRB or research committee and at least once a year in conversation with a trusted mentor. I will ask whether my actual decisions matched my stated values, what new dilemmas emerging technologies such as artificial intelligence and large data sets raise for consent and privacy and where pressure to publish or obtain funding tempted me to compromise. Through ongoing reflection, prayer and accountability, I hope my philosophy will mature so that my research career remains honest, courageous and consistent with my beliefs.

References

Beecher, H. K. (1966). Ethics and clinical research. New England Journal of Medicine, 274(24), 1354–1360. https://doi.org/10.1056/NEJM196606162742405

Brandt, A. M. (1978). Racism and research: The case of the Tuskegee Syphilis Study. Hastings Center Report, 8(6), 21–29. https://doi.org/10.2307/3561468

Emanuel, E. J., Wendler, D., & Grady, C. (2000). What makes clinical research ethical? JAMA, 283(20), 2701–2711. https://doi.org/10.1001/jama.283.20.2701

English Standard Version Bible. (2016). Crossway. (Original work published 2001)

Fanelli, D. (2009). How many scientists fabricate and falsify research? A systematic review and meta-analysis of survey data. PLoS ONE, 4(5), Article e5738. https://doi.org/10.1371/journal.pone.0005738

Godlee, F., Smith, J., & Marcovitch, H. (2011). Wakefield’s article linking MMR vaccine and autism was fraudulent. BMJ, 342, Article c7452. https://doi.org/10.1136/bmj.c7452

International Committee of Medical Journal Editors. (n.d.). Defining the role of authors and contributors. https://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html

Mello, M. M., & Wolf, L. E. (2010). The Havasupai Indian Tribe case: Lessons for research involving stored biologic samples. New England Journal of Medicine, 363(3), 204–207. https://doi.org/10.1056/NEJMp1005203

National Academies of Sciences, Engineering, and Medicine. (2019). The science of effective mentorship in STEMM. The National Academies Press. https://doi.org/10.17226/25568

National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. (1979). The Belmont report: Ethical principles and guidelines for the protection of human subjects of research. U.S. Department of Health, Education, and Welfare.

National Institutes of Health. (2020). Final NIH policy for data management and sharing (NOT-OD-21-013). https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-013.html

Office of Laboratory Animal Welfare. (2015). Public Health Service policy on humane care and use of laboratory animals. National Institutes of Health.

Protection of Human Subjects, 45 C.F.R. § 46 (2018).

Russell, W. M. S., & Burch, R. L. (1959). The principles of humane experimental technique. Methuen.

Shamoo, A. E., & Resnik, D. B. (2022). Responsible conduct of research (4th ed.). Oxford University Press.

World Medical Association. (2024). WMA Declaration of Helsinki: Ethical principles for medical research involving human participants. https://www.wma.net/policies-post/wma-declaration-of-helsinki/

More model assignments posted today

• Leadership models in an educational setting
• Final clinical reflection (DFC)
• VTE prevention teaching handout
• CJUS 801 evaluation strategy and logic model
• Modified working definition of family
• Initial working definition of family
• Two areas of life: mindfulness and strengths
• Special education lesson plan unit
• Global dynamics presentation